- Home
- PGNY vs ARDX Comparison
PGNY vs ARDX Comparison
Compare PGNY & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGNY
- ARDX
- Stock Information
- Founded
- PGNY 2008
- ARDX 2007
- Country
- PGNY United States
- ARDX United States
- Employees
- PGNY N/A
- ARDX N/A
- Industry
- PGNY Misc Health and Biotechnology Services
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- PGNY Health Care
- ARDX Health Care
- Exchange
- PGNY Nasdaq
- ARDX Nasdaq
- Market Cap
- PGNY 1.2B
- ARDX 1.2B
- IPO Year
- PGNY 2019
- ARDX 2014
- Fundamental
- Price
- PGNY $21.48
- ARDX $4.91
- Analyst Decision
- PGNY Buy
- ARDX Buy
- Analyst Count
- PGNY 9
- ARDX 7
- Target Price
- PGNY $19.17
- ARDX $10.58
- AVG Volume (30 Days)
- PGNY 2.3M
- ARDX 5.0M
- Earning Date
- PGNY 02-25-2025
- ARDX 02-20-2025
- Dividend Yield
- PGNY N/A
- ARDX N/A
- EPS Growth
- PGNY 17.45
- ARDX N/A
- EPS
- PGNY 0.60
- ARDX N/A
- Revenue
- PGNY $1,138,730,000.00
- ARDX $251,849,000.00
- Revenue This Year
- PGNY $7.20
- ARDX $168.07
- Revenue Next Year
- PGNY $1.11
- ARDX $16.66
- P/E Ratio
- PGNY $35.83
- ARDX N/A
- Revenue Growth
- PGNY 10.24
- ARDX 87.57
- 52 Week Low
- PGNY $13.39
- ARDX $4.32
- 52 Week High
- PGNY $42.08
- ARDX $10.13
- Technical
- Relative Strength Index (RSI)
- PGNY 80.28
- ARDX 44.85
- Support Level
- PGNY $19.94
- ARDX $4.98
- Resistance Level
- PGNY $18.40
- ARDX $6.07
- Average True Range (ATR)
- PGNY 0.85
- ARDX 0.37
- MACD
- PGNY 0.39
- ARDX -0.01
- Stochastic Oscillator
- PGNY 95.70
- ARDX 4.92
About PGNY Progyny Inc.
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.